Try our Advanced Search for more refined results
Health - December, 2003
38 articles
- Cholestech, Roche Settle on Cholesterol Kit
- Shire Sues IMPAX Over ANDA for Adderall Generic
- Glaxo Sues Dr. Reddy's Over Generic Imitrex
- N.Y. Court Issues Preliminary Injunction on Generic Wellbutrin
- Federal Circuit Rules for Pfizer in Suit Vs. Ranbaxy
- Judge Bars Antitrust Claims in MedImmune's Patent Suit Vs. Genentech
- Wockhardt Becomes First Indian Drug Maker to Receive EMR
- Brazil Threatens to Import Indian Copy of Roche Anti-HIV Drug
- Amended Patent Bill Introduced in India's Parliament
- Chinese Court Rejects J&J Trademark Suit
- Indian Drug Makers Seek Exemption From Patent Law Amendments
- University of California Sues Medical Device Makers Over Aneurism Treatment
- Genentech, Protein Design Settle Patent License Dispute
- Dutch Supreme Court Sustains Immunomedics Patent
- FTC Ruling Against Schering-Plough Seen Curtailing Settlement Terms
- India Readies Bills to Amend Patent, Drug Laws
- European Parliament Passes Pharmaceutical Regulatory Reform
- Dutch Court Rules Boston Scientific's Taxus Infringed Medinol Patent
- Shire Pharma Vs. Barr Trial Moved To Jan. 2006
- Judge Extends Block on Generic Wellbutrin
- European Patent Office Revokes Patent for Cellergy Nitroglycerin Ointment
- U.S., European Courts Deal Another Blow to AstraZeneca's Ulcer Drug
- University of Alberta Sues AMDL Over Technology Transfer
- Elan Seeks Arbitration With Pfizer Over Alzheimer Research
- Lawsuit Looms as Pennie Plans to Wind Down
- Glaxo, Boehringer Ingelheim Agree to Expand Anti-HIV Licensing in South Africa
- B&L Sues Four Rivals Over Eye Vitamin Patents
- Brazil Threatens to Break Roche's HIV/AIDS Drug Patent
- India to Push for Early Passage of Patents Bill
- U.S. House Passes Ban on Human-Organism Patents
- Solae Sues ADM, Amerifit Over Soy Supplement Patents
- Barr to Challenge Patents Protecting Prefest Hormone Therapy
- Advanced Medical Optics Sues Alcon Over Medical Device Patents
- Judge Blocks Approval of ANDA for Wellbutrin
- India Plans Data Protection of Up to 5 Years for Pharma Patents
- Genentech, Protein Design Labs Settle Patent Suits
- Judge Extends Restraining Order on Generic Wellbutrin
- U.S. Supreme Court Rejects Appeal Over Patents for Off-Market Uses of Drugs